![]() |
市場調查報告書
商品編碼
1936669
負壓傷口治療市場機會、成長要素、產業趨勢分析及2026年至2035年預測Negative Pressure Wound Therapy Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
全球負壓傷口治療 (NPWT) 市場預計到 2025 年將達到 22 億美元,到 2035 年將達到 38 億美元,年複合成長率為 5.8%。

糖尿病盛行率上升、外科手術量增加以及全球急慢性傷口負擔加重,推動了負壓傷口治療(NPWT)市場的穩定成長。科技創新重塑了NPWT,現代系統更加緊湊便攜,並配備了物聯網感測器和即時壓力監測等智慧功能,使醫護人員能夠遠端追蹤創傷治療,確保治療的一致性。一次性裝置和自動壓力控制等創新技術提高了便利性,降低了感染風險,並有助於居家照護。 NPWT透過連接真空幫浦的封閉式敷料施加可控的減壓,仍然是一項重要的創傷護理技術,能夠促進傷口癒合,改善組織肉芽組織,並降低急慢性傷口的併發症率。
| 市場覆蓋範圍 | |
|---|---|
| 開始年份 | 2025 |
| 預測年份 | 2026-2035 |
| 起始值 | 22億美元 |
| 預測金額 | 38億美元 |
| 複合年成長率 | 5.8% |
預計到2025年,急性傷口市場規模將達到13億美元,佔市佔率的60.2%。手術切口、創傷和燒傷是推動負壓傷口治療(NPWT)應用的主要因素,因為這些傷口需要更快癒合和預防感染。 NPWT裝置因其促進組織再生、減輕腫脹和改善患者整體預後(尤其是在複雜手術和急診手術中)而日益受到青睞,優於傳統敷料。
到2025年,醫院將佔據42.6%的市場佔有率,成為負壓傷口治療(NPWT)系統的主要終端用戶。醫院能夠維持大量的庫存,並在急診情況下提供及時的護理,這確保了NPWT的持續普及。擁有先進基礎設施和高效採購流程的醫院為NPWT的推廣應用提供了理想的環境,尤其適用於需要即時介入的高風險傷口。攜帶式、技術賦能系統的整合,使醫護人員能夠在普通患者照護和重症監護室提供高效的治療。
美國負壓傷口治療(NPWT)市場預計到2025年將達到7.173億美元。這一成長主要得益於慢性傷口的高發生率以及美國先進的醫療保健基礎設施。遍佈全國的醫院、診所和專科治療中心網路,使得患者能夠方便地獲得NPWT技術,從而推動了市場成長。
The Global Negative Pressure Wound Therapy Market was valued at USD 2.2 billion in 2025 and is estimated to grow at a CAGR of 5.8% to reach USD 3.8 billion by 2035.

The market's steady growth is driven by the rising prevalence of diabetes, the increasing number of surgical procedures, and the growing burden of chronic and acute wounds worldwide. Technological advancements have reshaped NPWT, making modern systems more compact, portable, and equipped with smart features such as IoT-enabled sensors and real-time pressure monitoring, allowing clinicians to track wound healing remotely and ensure consistent therapy. Innovations like single-use devices and automated pressure control enhance convenience, reduce infection risks, and support home-based care. NPWT remains a critical wound care technique, using controlled sub-atmospheric pressure through a sealed dressing connected to a vacuum pump to accelerate healing in both acute and chronic wounds, improve tissue granulation, and lower complication rates.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $2.2 Billion |
| Forecast Value | $3.8 Billion |
| CAGR | 5.8% |
The acute wound segment accounted for USD 1.3 billion in 2025, representing 60.2% share. Surgical incisions, traumatic injuries, and burns are driving NPWT adoption due to their need for faster healing and infection prevention. NPWT devices are increasingly preferred over traditional dressings because they promote tissue regeneration, reduce swelling, and enhance overall patient outcomes, particularly in complex or emergency surgical cases.
The hospitals segment held 42.6% share in 2025, serving as the primary end users of NPWT systems. Their ability to maintain extensive inventories and deliver timely care in acute situations ensures consistent adoption. Hospitals with advanced infrastructure and streamlined procurement processes provide an ideal setting for NPWT deployment, especially for high-risk wounds where immediate intervention is critical. The integration of portable, technology-enabled systems allows healthcare providers to deliver efficient care in both inpatient and critical care environments.
U.S. Negative Pressure Wound Therapy Market USD 717.3 million in 2025. Growth is driven by the high prevalence of chronic wounds and the country's advanced healthcare infrastructure, supported by a vast network of hospitals, clinics, and specialized care centers that facilitate access to NPWT technologies.
Key players operating in the Global Negative Pressure Wound Therapy Market include 4L Health & Foryou Medical Electronics, ATMOS MedizinTechnik, Cardinal Health, Carilex Medical, Convatec, DeRoyal Industries, Genadyne Biotechnologies, Lohmann & Rauscher International, Medaxis, Molnlycke, PAUL HARTMANN, Smith+Nephew, Solventum, Talley Group, and Weigao Group. Companies in the negative pressure wound therapy market strengthen their foothold by investing in innovative product development, enhancing portability, and integrating smart monitoring features. They focus on expanding home care solutions and single-use devices to meet patient convenience and safety demands. Strategic collaborations with hospitals, clinics, and surgical centers allow co-development of tailored therapies and clinical trials to improve outcomes. Companies also expand geographically, establish robust distribution channels, and offer comprehensive after-sales support, training, and education to clinicians. Marketing campaigns highlighting clinical efficacy, cost-effectiveness, and infection prevention further strengthen brand trust and adoption globally.